This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Valneva Austria Gmbh. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: **Stefan Seidel: Innovator in Nucleic Acid Molecule Technologies**
Introduction
Stefan Seidel is a distinguished inventor based in Wiener Neustadt, Austria, known for his contributions to the field of biotechnology. With a focus on isolated nucleic acid molecules and the production of antigens, his work addresses important aspects of bacterial infections, particularly those caused by nontypable species.
Latest Patents
Seidel holds one patent that showcases a significant advancement in the field. The invention pertains to isolated nucleic acid molecules that encode an antigen from a nontypable species. His patent also includes a novel vector that incorporates these nucleic acid molecules, alongside a host cell which comprises such a vector. The invention outlines processes for producing antigens associated with bacterial infections, methods for generating antibodies that bind to the antigens, and the creation of pharmaceutical compositions utilizing these innovative components.
Career Highlights
Stefan Seidel's career includes notable achievements while working with Valneva Austria GmbH, a company recognized for its pioneering work in vaccine development and biotechnology. His research is instrumental in the ongoing efforts to develop effective diagnostics and treatments for infections caused by nontypable bacteria, which are crucial for public health.
Collaborations
Stefan collaborates with esteemed colleagues such as Alexander Von Gabain and Eszter Nagy, both of whom contribute their expertise to enhance the innovative capabilities of their projects. Together, they are advancing the understanding and potential therapeutic interventions related to nontypable bacterial infections.
Conclusion
Through his work, Stefan Seidel is making significant strides in biomedical research and innovation. His patent represents a leap forward in understanding and combating bacterial infections, highlighting the importance of collaboration and innovation in the scientific community. As he continues to develop new technologies, his contributions will likely pave the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile